MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617046368 A) filed by Tessera Therapeutics, Inc. on April 10, 2026, for Lipid Nanoparticles For Delivery Of Therapeutic Payloads To Cells.
Inventors include Wang, Zhan; Zhang, Rui; Gu, Han; Wangweerawong, Apiwat; Tozzi, Lorenzo; Palchaudhuri, Rahul; Monte, Michael; Schiroli, Giulia; and Liu, Lei.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The disclosure provides lipid nanoparticles (LNPS) and conjugates comprising a targeting moiety and a lipid nanoparticle (LNP) encapsulating a therapeutic agent (e.g., payload) for delivery to hematopoietic stem cells (HSCs). The conjugates can be formulated in a pharmaceutical composition and can be directly administered to a subject in need of treatment (e.g., via in vivo administration).
Disclaimer: Curated by HT Syndication.
